Zhiming Mao

6PUBLICATIONS

35CO-AUTHORS

Tumour immunologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|May 23, 2026

PD-1 regulates latent effector differentiation of thymic cytotoxic CD8+ T cells.

|Aug 18, 2025

A Dual Role for NKG7 in T-cell Cytotoxicity and Longevity.

Haidong Dong, Hyoungjun Ham, Whitney Barham

|Feb 14, 2025

Lysosomal NKG7 restrains mTORC1 activity to promote CD8+ T cell durability and tumor control.

Hyoungjun Ham, Jacob B Hirdler, Daniel T Bihnam

|Jan 27, 2025

PD-1 prelimits both the cytotoxic and exhaustion potential in thymic CD8+ T cells and impacts the maintenance of peripheral tumor immunity.

Zhiming Mao, Jacob B Hirdler, Joanina K Gicobi

|Nov 15, 2023

Salvage therapy expands highly cytotoxic and metabolically fit resilient CD8+ T cells via ME1 up-regulation.

Joanina K Gicobi, Zhiming Mao, Grace DeFranco

|Jul 28, 2023

Clinical and cellular phenotypes resulting from a founder mutation in IL10RB.

Zhiming Mao, Michael J Betti, Miguel A Cedeno

Pageof 1

Frequent Collaborators

4 joint publications

Haidong Dong

3 joint publications

Daniel D Billadeau

3 joint publications

Fabrice Lucien-Matteoni

2 joint publications

Henrique Borges da Silva

Michelle A Hsu

Whitney Barham

Hyoungjun Ham

Joanina K Gicobi

Emilia R Dellacecca

Aaron S Mansfield

Frequent Collaborators

4 joint publications

Haidong Dong

3 joint publications

Daniel D Billadeau

3 joint publications

Fabrice Lucien-Matteoni

2 joint publications

Henrique Borges da Silva